The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Results of the CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in renal cell carcinoma, were presented at JADPRO 2025.

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.